BIOGEN MA INC.

IMPLANTABLE MEDICAL DEVICE FOR USE WITH OR HAVING RECORDING ELECTRODE

#2 | 2026-04-16

US20260103465A1

GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF

#3 | 2026-02-12

US20260042818A1

ANTI-TNF-ALPHA POLYPEPTIDE COMPOSITION AND USE THEREOF

#4 | 2025-12-18

US20250382568A1

USE OF PERFUSION SEED CULTURES TO IMPROVE BIOPHARMACEUTICAL FEDBATCH PRODUCTION CAPACITY AND PRODUCT QUALITY

#5 | 2025-11-20

US20250352721A1

IMPLANTABLE INTRAVENTRICULAR SAMPLING AND INFUSION ACCESS DEVICE

#6 | 2025-10-09

US20250313563A1

GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF

#7 | 2025-09-11

US20250282883A1

ANTI-BCMA ANTIBODIES

#8 | 2025-09-04

US20250276042A1

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

#9 | 2025-01-02 ✅ Patent 12,392,784 granted on 2025-08-19

US20250003983A1

METHOD OF ASSESSING RISK OF PML

#10 | 2024-10-03

US20240327380A1

BTK INHIBITORS

#11 | 2024-09-19 ✅ Patent 12,275,728 granted on 2025-04-15

US20240308995A1

O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors

#12 | 2024-07-18

US20240238326A1

COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT

#13 | 2024-05-09

US20240150723A1

REDUCING HOST CELL IMPURITIES DURING RECOMBINANT PROTEIN PRODUCTION

#14 | 2024-04-04 ✅ Patent 12,404,263 granted on 2025-09-02

US20240109867A1

ASK1 INHIBITING AGENTS

#15 | 2024-03-28

US20240100155A1

ANTI-VLA-4 ANTIBODIES

#16 | 2024-03-14

US20240083900A1

PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS

#17 | 2024-02-01

US20240037748A1

METHODS FOR CLASSIFICATION OF LESIONS AND FOR PREDICTING LESION DEVELOPMENT

#18 | 2023-12-07

US20230391820A1

HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS

#19 | 2023-10-12 ✅ Patent 12,091,662 granted on 2024-09-17

US20230323351A1

Compositions for modulating tau expression

#20 | 2023-10-05 ✅ Patent 12,472,171 granted on 2025-11-18

US20230310405A1

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

#21 | 2023-09-07 ✅ Patent 12,605,537 granted on 2026-04-21

US20230277840A1

IMPLANTABLE MEDICAL DEVICE FOR USE WITH OR HAVING RECORDING ELECTRODE

#22 | 2023-06-15 ✅ Patent 12,467,929 granted on 2025-11-11

US20230184780A1

METHODS OF DETECTING UBE3A PROTEIN

#23 | 2023-06-15

US20230183696A1

Compositions and Methods for Modulation of SMN2 Splicing in a Subject

#24 | 2023-06-08 ✅ Patent 12,372,470 granted on 2025-07-29

US20230175967A1

USE OF RAMAN SPECTROSCOPY TO MONITOR CULTURE MEDIUM

#25 | 2023-06-08

US20230174511A1

PYRIMIDINYL TYROSINE KINASE INHIBITORS

#26 | 2023-05-11 ✅ Patent 11,858,926 granted on 2024-01-02

US20230147490A1

Inhibiting agents for bruton's tyrosine kinase

#27 | 2023-04-27 ✅ Patent 11,827,702 granted on 2023-11-28

US20230131379A1

Anti-transferrin receptor antibodies and uses thereof

#28 | 2023-04-20 ✅ Patent 12,570,631 granted on 2026-03-10

US20230121818A1

BTK INHIBITORS

#29 | 2023-04-13

US20230112162A1

COGNITIVE SCREENING METHODS

#30 | 2023-04-06

US20230107651A1

METHODS OF TREATING SPINAL MUSCULAR ATROPHY

#31 | 2023-03-16 ✅ Patent 12,607,638 granted on 2026-04-21

US20230082238A1

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

#32 | 2023-03-02

US20230061636A1

ASSESSING A PATIENT STATE

#33 | 2023-02-23 ✅ Patent 12,565,504 granted on 2026-03-03

US20230060003A1

SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

#34 | 2023-01-26 ✅ Patent 12,391,697 granted on 2025-08-19

US20230025892A1

CONDENSED BI-HETEROCYCLES AS INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE

#35 | 2022-12-29 ✅ Patent 12,565,500 granted on 2026-03-03

US20220411429A1

CONDENSED PYRIDAZINE OR PYRIMIDINE AS BTK INHIBITORS

#36 | 2022-12-29 ✅ Patent 12,357,569 granted on 2025-07-15

US20220409530A1

INFUSING DRUG SOLUTION DIRECTLY INTO BRAIN FLUID

#37 | 2022-12-15 ✅ Patent 12,345,703 granted on 2025-07-01

US20220397571A1

ASSAY FOR JC VIRUS ANTIBODIES

#38 | 2022-11-24 ✅ Patent 11,854,198 granted on 2023-12-26

US20220375083A1

Methods for improved measurements of brain volume and changes in brain volume

#39 | 2022-11-10 ✅ Patent 12,031,990 granted on 2024-07-09

US20220357339A1

Method of assessing risk of PML

#40 | 2022-11-10 ✅ Patent 12,385,925 granted on 2025-08-12

US20220357338A1

ANTI-VLA-4 RELATED ASSAYS

#41 | 2022-11-03

US20220348623A1

STABILIZED PROTEOLYTICALLY ACTIVATED GROWTH DIFFERENTIATION FACTOR 11

#42 | 2022-11-03 ✅ Patent 12,378,276 granted on 2025-08-05

US20220348602A1

CONVERGENT LIQUID PHASE SYNTHESES OF OLIGONUCLEOTIDES

#43 | 2022-10-20 ✅ Patent 11,572,356 granted on 2023-02-07

US20220332705A1

Biaryl inhibitors of Bruton's tyrosine kinase

#44 | 2022-10-06 ✅ Patent 11,753,668 granted on 2023-09-12

US20220315973A1

Copper supplementation for control of glycosylation in mammalian cell culture process

#45 | 2022-09-29 ✅ Patent 12,018,046 granted on 2024-06-25

US20220306684A1

Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications

#46 | 2022-09-08

US20220280610A1

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

#47 | 2022-09-08

US20220280548A1

COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY

#48 | 2022-08-18 ✅ Patent 12,421,224 granted on 2025-09-23

US20220259197A1

AZETIDINYL O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

#49 | 2022-08-18 ✅ Patent 12,240,838 granted on 2025-03-04

US20220259194A1

Inhibiting agents for Bruton's tyrosine kinase

#50 | 2022-07-07 ✅ Patent 12,441,980 granted on 2025-10-14

US20220213431A1

METHODS FOR OVERCOMING GLUTAMINE DEPRIVATION DURING MAMMALIAN CELL CULTURE

#51 | 2022-07-07

US20220213208A1

ANTI-BCMA ANTIBODIES

#52 | 2022-07-07

US20220213200A1

ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF

#53 | 2022-05-19 ✅ Patent 12,162,952 granted on 2024-12-10

US20220153874A1

Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibody

#54 | 2022-04-28 ✅ Patent 12,656,353 granted on 2026-06-16

US20220128578A1

BIOMARKERS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY

#55 | 2022-04-14 ✅ Patent 12,486,289 granted on 2025-12-02

US20220112216A1

TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF

#56 | 2022-04-14 ✅ Patent 12,233,248 granted on 2025-02-25

US20220111149A1

Smart injector

#57 | 2022-04-07 ✅ Patent 12,522,595 granted on 2026-01-13

US20220106305A1

BICYCLIC ETHER O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

#58 | 2022-03-24

US20220089745A1

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

#59 | 2022-03-10

US20220072117A1

Dimethyl Fumarate and Vaccination Regimens

#60 | 2022-02-17

US20220049301A1

BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS

#61 | 2022-02-10 ✅ Patent 12,180,205 granted on 2024-12-31

US20220041586A1

O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

#62 | 2022-02-03 ✅ Patent 12,429,487 granted on 2025-09-30

US20220034907A1

NEUROFILAMENT PROTEIN FOR GUIDING THERAPEUTIC INTERVENTION IN AMYOTROPHIC LATERAL SCLEROSIS

#63 | 2022-01-20 ✅ Patent 12,319,679 granted on 2025-06-03

US20220017506A1

Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

#64 | 2022-01-20 ✅ Patent 12,551,669 granted on 2026-02-17

US20220016402A1

MEDICAL SYSTEM INCLUDING TWO ACCESS PORTS

#65 | 2022-01-13 ✅ Patent 12,066,442 granted on 2024-08-20

US20220011310A1

Method of assessing risk of PML

#66 | 2021-12-30 ✅ Patent 11,571,477 granted on 2023-02-07

US20210401981A1

Anti-VLA-4 antibodies

#67 | 2021-12-23

US20210395360A1

SP35 Antibodies And Uses Thereof

#68 | 2021-12-16 ✅ Patent 12,013,403 granted on 2024-06-18

US20210389335A1

Compositions and methods for detection of SMN protein in a subject and treatment of a subject

#69 | 2021-12-16 ✅ Patent 11,820,760 granted on 2023-11-21

US20210387972A1

Crystalline polymorphs of Bruton's tyrosine kinase inhibitors

#70 | 2021-11-04

US20210340584A1

MANGANESE SUPPLEMENTATION FOR CONTROL OF GLYCOSYLATION IN MAMMALIAN CELL CULTURE PROCESS

#71 | 2021-11-04 ✅ Patent 11,427,577 granted on 2022-08-30

US20210340135A1

Inhibiting agents for Bruton's tyrosine kinase

#72 | 2021-10-21

US20210324321A9

CROSS-SCALE MODELING OF BIOREACTOR CULTURES USING RAMAN SPECTROSCOPY

#73 | 2021-10-21 ✅ Patent 11,884,737 granted on 2024-01-30

US20210324095A1

Treatment of autoimmune disorders with CD154 antibodies

#74 | 2021-10-21 ✅ Patent 11,850,232 granted on 2023-12-26

US20210322381A1

Drug for treating or preventing cerebral hemorrhage, and method for treating or preventing cerebral hemorrhage using the drug

#75 | 2021-10-14 ✅ Patent 11,999,715 granted on 2024-06-04

US20210317103A1

ASK1 inhibiting agents

#76 | 2021-10-14 ✅ Patent 11,246,850 granted on 2022-02-15

US20210315854A1

Methods of treating multiple sclerosis

#77 | 2021-10-07 ✅ Patent 11,834,491 granted on 2023-12-05

US20210309719A1

Arginine-free TNFR:FC-fusion polypeptide compositions

#78 | 2021-10-07

US20210308281A1

COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY

#79 | 2021-09-30

US20210301002A1

ANTI-HSPA5 ANTIBODIES AND USES THEREOF

#80 | 2021-09-30 ✅ Patent 11,897,898 granted on 2024-02-13

US20210300946A1

Pyridine macrocycle compounds as ASK1 inhibiting agents

#81 | 2021-08-26

US20210260185A1

Combination Therapies and Uses for Treatment of Demyelinating Disorders

#82 | 2021-08-19 ✅ Patent 11,318,120 granted on 2022-05-03

US20210251968A1

Nuclear transport modulators and uses thereof

#83 | 2021-08-05 ✅ Patent 12,037,398 granted on 2024-07-16

US20210238289A1

Anti-VLA-4 antibodies having reduced effector function

#84 | 2021-07-29

US20210228701A1

Dimethyl Fumarate and Vaccination Regimens

#85 | 2021-06-24 ✅ Patent 11,655,289 granted on 2023-05-23

US20210188954A1

Pharmaceutical compositions containing anti-beta amyloid antibodies

#86 | 2021-06-24 ✅ Patent 11,427,561 granted on 2022-08-30

US20210188809A1

IRAK4 inhibiting agents

#87 | 2021-05-06 ✅ Patent 11,697,670 granted on 2023-07-11

US20210130397A1

Methods for purifying antibodies having reduced high molecular weight aggregates

#88 | 2021-04-22 ✅ Patent 11,814,362 granted on 2023-11-14

US20210115020A1

ASK1 inhibiting agents

#89 | 2021-04-08 ✅ Patent 11,287,423 granted on 2022-03-29

US20210102939A1

Assay for JC virus antibodies

#90 | 2021-03-11 ✅ Patent 11,591,595 granted on 2023-02-28

US20210071176A1

Compositions for modulating Tau expression

#91 | 2021-02-11 ✅ Patent 11,459,324 granted on 2022-10-04

US20210040080A1

O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors

#92 | 2021-02-04 ✅ Patent 11,535,848 granted on 2022-12-27

US20210032624A1

Compositions and methods for modulation of SMN2 splicing in a subject

#93 | 2021-02-04 ✅ Patent 11,174,243 granted on 2021-11-16

US20210032218A1

Succinate forms and compositions of Bruton's tyrosine kinase inhibitors

#94 | 2021-01-28 ✅ Patent 11,699,506 granted on 2023-07-11

US20210027873A1

Method for distribution of a drug

#95 | 2021-01-28 ✅ Patent 11,686,734 granted on 2023-06-27

US20210025900A1

Methods and products for evaluating an immune response to a therapeutic protein

#96 | 2021-01-28 ✅ Patent 11,007,167 granted on 2021-05-18

US20210023040A1

Methods of treating multiple sclerosis

#97 | 2020-12-31 ✅ Patent 11,280,794 granted on 2022-03-22

US20200408776A1

Method of assessing risk of PML

#98 | 2020-12-17 ✅ Patent 12,516,280 granted on 2026-01-06

US20200392447A1

CROSS-SCALE MODELING OF BIOREACTOR CULTURES USING RAMAN SPECTROSCOPY

#99 | 2020-12-03

US20200376018A1

COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT

#100 | 2020-11-19 ✅ Patent 11,292,826 granted on 2022-04-05

US20200362009A1